Employment Verification for Adaptive Biotechnologies.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a biotechnology company founded in 2009, based in Seattle, Washington. The company specializes in developing and providing advanced technologies for sequencing the human immune system. Its core technology, Adaptive Immune Repertoire Sequencing (AIRS), is a high-throughput platform that analyzes diversity, identity, and clonality of T and B cells in the immune system. This allows for the identification of potential biomarkers that may be utilized in the diagnosis, monitoring, and treatment of various diseases, such as cancer, autoimmune disorders, and infectious diseases. Adaptive Biotechnologies has developed several products and services, including immunoSEQ, the first clinical immunosequencing platform for measuring immune status and clonality, and T-Detect, a blood test for the direct detection of COVID-19-specific T cells. The company has also established partnerships with various pharmaceutical and biotechnology companies to leverage its technology in the development of novel therapeutics. As of 2021, Adaptive Biotechnologies has a team of over 650 employees, has raised over $1 billion in funding, and is publicly traded on the NASDAQ stock exchange under the ticker symbol ADPT. The company has received numerous awards and recognition for its groundbreaking technology and contribution to the field of precision medicine.

The information on this page is not an endorsement of Truv’s services by Adaptive Biotechnologies and is meant to be purely informational.

Verify Adaptive Biotechnologies Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.